MAB1900
Anti-Integrin β1D Antibody, CT cytoplasmic domain, clone 2B1
clone 2B1, Chemicon®, from mouse
Synonym(s):
CD29
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Recommended Products
biological source
mouse
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
2B1, monoclonal
species reactivity
canine, human, mouse
manufacturer/tradename
Chemicon®
technique(s)
immunocytochemistry: suitable
immunohistochemistry: suitable
western blot: suitable
isotype
IgG1
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Gene Information
human ... ITGB1(3688)
General description
Integrins are a family of heterodimeric membrane glycoproteins consisting of non-covalently associated alpha and beta subunits. More than 18 alpha and 8 beta subunits with numerous splice variant isoforms have been identified in mammals. In general, integrins function as receptors for extracellular matrix proteins. Certain integrins can also bind to soluble ligands or to counter-receptors on adjacent cells, such as the intracellular adhesion molecules (ICAMs), resulting in aggregation of cells. Signals transduced by integrins play a role in many biological processes, including cell growth, differentiation, migration and apoptosis. There are two major forms of integrin beta 1:beta 1A and beta 1D which differ in 13 amino acids. Their distribution pattern in adult tissues is mutually exclusive. Beta1A is present in all tissues, except cardiac and skeletal muscle, which instead express the beta1D variant.
Specificity
MAB1900 is specific for the cytoplasmic domain of integrin beta1D subunit. Integrin beta1D is present in cardiac and skeletal muscle. In proliferating C2C12 cells, beta1D is not expressed; C2C12 after differentiation into myotubes, however, express high levels of beta1D integrin. beta1D integrin was also found expressed in adult mouse extracts from heat, hind limb muscle, and tongue, with a faint band in skin. No reactivity was observed in extracts from lung, kidney, liver, or spleen {van der Flier et al, 1997}.
Immunogen
Epitope: C-terminus cytoplasmic domain
Synthetic peptide including an appending N-terminal cysteine: CQENPIYKSPINNFKNPNYGRKAGL coupled to KLH.
Application
Research Category
Cell Structure
Cell Structure
Research Sub Category
Integrins
Integrins
This Anti-Integrin β1D Antibody, C-terminus cytoplasmic domain, clone 2B1 is validated for use in WB, IC, IH for the detection of Integrin β1D.
Western Blotting: 1:100-1:1000; recognizes a 116kDa band in reduced, 7% PAGE-SDS westerns in differentiated C2C12 cells and some adult tissues {See van der Flier, 1997}. 1% SDS lysis buffer is recommended over RIPA or traditional reducing sample buffer.
Immunocytochemistry:
Immunohistochemistry: 1:25-1:200. Frozen, unfixed tissue sections, post-fixed with 2% PFA after primary and secondary antibody additions {van der Flier, 1997}. Alternatively, 4-7μm cyrosections fixed with cold acetone for 2 minutes and stored at -80°C until used. Airdried sections are rehydrated in PBS prior to use; detection via ABC systems is encouraged.
Optimal working dilutions must be determined by the end user.
Immunocytochemistry:
Immunohistochemistry: 1:25-1:200. Frozen, unfixed tissue sections, post-fixed with 2% PFA after primary and secondary antibody additions {van der Flier, 1997}. Alternatively, 4-7μm cyrosections fixed with cold acetone for 2 minutes and stored at -80°C until used. Airdried sections are rehydrated in PBS prior to use; detection via ABC systems is encouraged.
Optimal working dilutions must be determined by the end user.
Physical form
Format: Purified
Purified immunoglobulin. Liquid in PBS containing 0.09% sodium azide.
Storage and Stability
Maintain at 2-8°C in undiluted aliquots for up to 12 months from date of receipt.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
recommended
Product No.
Description
Pricing
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Inhibition of collagen XVI expression reduces glioma cell invasiveness.
Bauer, R; Ratzinger, S; Wales, L; Bosserhoff, A; Senner, V; Grifka, J; Grassel, S
Cellular Physiology and Biochemistry null
Michelle H Kim et al.
Human molecular genetics, 20(7), 1324-1338 (2011-01-20)
Duchenne muscular dystrophy, the most common form of childhood muscular dystrophy, is caused by X-linked inherited mutations in the dystrophin gene. Dystrophin deficiencies result in the loss of the dystrophin-glycoprotein complex at the plasma membrane, which leads to structural instability
Andoria Tjondrokoesoemo et al.
Human molecular genetics, 25(6), 1192-1202 (2016-01-09)
Muscular dystrophy (MD) is associated with mutations in genes that stabilize the myofiber plasma membrane, such as through the dystrophin-glycoprotein complex (DGC). Instability of this complex or defects in membrane repair/integrity leads to calcium influx and myofiber necrosis leading to
Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx mice.
J?rgensen, LH; Jensen, CH; Wewer, UM; Schr?der, HD
The American Journal of Pathology null
Michelle S Parvatiyar et al.
JCI insight, 5 (2019-05-01)
In the current preclinical study, we demonstrate the therapeutic potential of sarcospan (SSPN) overexpression to alleviate cardiomyopathy associated with Duchenne muscular dystrophy (DMD) utilizing dystrophin-deficient mdx mice with utrophin haploinsufficiency that more accurately represent the severe disease course of human
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service